Cargando…
Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy
Oncolytic viruses (OV) are a class of antitumor agents that selectively kill tumor cells while sparing normal cells. Oncolytic herpes simplex virus (oHSV) has been investigated in clinical trials for patients with the malignant brain tumor glioblastoma for more than a decade. These clinical studies...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064532/ https://www.ncbi.nlm.nih.gov/pubmed/24999342 http://dx.doi.org/10.3389/fmicb.2014.00303 |